The U.S. Food and Drug Administration has approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults.
This Wednesday, the Universitat Oberta de Catalunya (UOC) launched the first academic centre in southern Europe specializing in eHealth, the eHealth Center, at an act held in the Sala Europa of the Representation of the European Commission in Barcelona. The act was attended by Josep A. Planell, President of the UOC; Marta Aymerich, Vice President for Strategic Planning and Research at the UOC; Antoni Comín, the Government of Catalonia's Minister for Health;
Page 11 of 46